Advertisement
Singapore markets closed
  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     
  • S&P 500

    4,998.19
    -73.44 (-1.45%)
     
  • Dow

    37,800.21
    -660.71 (-1.72%)
     
  • Nasdaq

    15,405.31
    -307.44 (-1.96%)
     
  • Bitcoin USD

    63,353.33
    -2,632.41 (-3.99%)
     
  • CMC Crypto 200

    1,371.39
    -11.18 (-0.81%)
     
  • FTSE 100

    8,053.12
    +12.74 (+0.16%)
     
  • Gold

    2,332.00
    -6.40 (-0.27%)
     
  • Crude Oil

    82.43
    -0.38 (-0.46%)
     
  • 10-Yr Bond

    4.7230
    +0.0710 (+1.53%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     
  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout

4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout

The recent acquisition of Dicerna Pharmaceuticals makes Arrowhead Pharmaceuticals look like the next biotech in line to receive a juicy buyout offer.